Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.

导出 OA

翻译打印收藏纠错

作者： Rushil,Harryparsad ^[1] ; Bahiah,Meyer ^[1] ; Ongeziwe,Taku ^[1] ; Myrna,Serrano ^[2] ; Pai Lien,Chen ^[3] ; Xiaoming,Gao ^[3] ; Anna-Lise,Williamson ^[1] ; Celia,Mehou-Loko ^[1] ; Florence Lefebvre,d'Hellencourt ^[3] ; Jennifer,Smit ^[4] ; Jerome,Strauss ^[5] ; Kavita,Nanda ^[3] ; Khatija,Ahmed ^[6] ; Mags,Beksinska ^[7] ; Gregory,Buck ^[4] ; Charles,Morrison ^[2] ; Jennifer,Deese ^[3] ; Lindi,Masson ^[8]

作者单位： Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa. ^[1] Virginia Commonwealth University, Richmond, Virginia, United State of America. ^[2] FHI 360, Durham, North Carolina, United States of America. ^[3] MRU, University of the Witwatersrand, Durban, South Africa. ^[4] Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA, United States of America. ^[5] Setshaba Research Centre, Pretoria, South Africa. ^[6] Faculty of Health Sciences, Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa8 Pfizer, Inc., Pennsylvania, PA, United States of America. ^[7] Disease Elimination Program, Life Sciences Discipline, Burnet Institute, Melbourne, Australia. ^[8] Centre for the AIDS Programme of Research in South Africa, Durban, South Africa. ^[9] Central Clinical School, Monash University, Melbourne, Australia. ^[10]